Earlier this year, the Food and Drug Administration made news by approving a direct-to-consumer (DTC) genetic testing option for hereditary breast and ovarian cancer (HBOC) syndrome through 23andMe. Explain what variants are tested, and the cancer risk associated with these variants.Discuss how useful these tests are in determining an individual’s risk of breast cancer, as well as potential concerns and benefits associated with this test.
divide the work into 4 sections:
– variants that tested
– cancer risk associated with these variants
– usefulnes of the tests in determining an individual’s risk of breast cancer
– potential concerns and benefits associated with the test.
– As usual use Vancouver referencing style and only high impact factor journals.
